+++
name = "DO53"
target = "ABHD6"
activity = "Inhibitor"
pubchem_cid = "129188755"
cas = "1848233-59-9"
systematic_name = "tert-butyl 3-phenyl-4-(4-(4-(trifluoromethoxy)phenyl)-1H-1,2,3-triazole-1-carbonyl)piperazine-1-carboxylate"
synonyms = []
molecular_weight = "517.51"


[[references]]
authors_list = "Ogasawara, D., Deng, H., Viader, A., Baggelaar, M. P., Breman, A., den Dulk, H., van den Nieuwendijk, A. M. C. H., Soethoudt, M., van der Wel, T., Zhou, J., Overkleeft, H. S., Sanchez-Alavez, M., Mori, S., Nguyen, W., Conti, B., Liu, X., Chen, Y., Liu, Q.-s., Cravatt, B. F., and van der Stelt, M."
title = "Rapid and profound rewiring of brain lipid signaling networks by acute diacylglycerol lipase inhibition"
journal = "Proc. Nat. Acad. Sci. USA"
year = 2016
volume = 113
pages = "26-33"
doi_link = "https://doi.org/10.1073/pnas.1522364112"
pubmed_link = "https://www.ncbi.nlm.nih.gov/pubmed/26668358"
[[references]]
authors_list = "Deng, H., Kooijman, S., van den Nieuwendijk, A. M. C. H., Ogasawara, D., van der Wel, T., van Dalen, F., Baggelaar, M. P., Janssen, F. J., van den Berg, R. J. B. H. N., den Dulk, H., Cravatt, B. F., Overkleeft, H. S., Rensen, P. C. N., and van der Stelt, M."
title = "Triazole Ureas Act as Diacylglycerol Lipase Inhibitors and Prevent Fasting-Induced Refeeding"
journal = "J. Med. Chem."
year = 2017
volume = 60
pages = "428-440"
doi_link = "https://doi.org/10.1021/acs.jmedchem.6b01482"
pubmed_link = "https://www.ncbi.nlm.nih.gov/pubmed/27992221"

+++

DO53 is a potent, in vivo active, covalent inhibitor of ABHD6, developed to control for the off-targets of DAGL inhibitors (including ABHD6) in vivo. DO53 selectively inhibited brain ABHD6 in mice (~100% inhibition at 10 mg·kg<sup>-1</sup>; &gt;90% at 10 mg·kg<sup>-1</sup>; 4 h, i.p.) with almost no discernable off-targets by gel profiling (except PLA2G7 at 10 mg·kg<sup>-1</sup>). At higher doses, DO53 showed cross-reactivity with other serine hydrolases, including (&gt;50% inhibition) PAFAH2, ABHD3, ABHD2, CES1C, and PLA2G7.
